Results 131 to 140 of about 81,579 (355)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Dyskinesia is a debilitating complication of dopaminergic therapy in advanced Parkinson's disease. Objectives To evaluate the effect of levodopa‐carbidopa intestinal gel (LCIG) on dyskinesia burden. Methods This is a post hoc analysis of the retrospective, observational COmedication Study assessing Mono‐ and cOmbination therapy with
Alfonso Fasano +11 more
wiley +1 more source
The Changing Face of Dystonia—Enhancing Diagnosis by Moving Beyond Traditional Clinical Phenotyping
Movement Disorders Clinical Practice, EarlyView.
Niroshan Jeyakumar, Kishore R. Kumar
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.ABSTRACT Background Levodopa‐carbidopa intestinal gel infusion (LCIG) is an effective therapy for advanced Parkinson's disease (PD). Opicapone (OPC) is an enzyme inhibitor that enhances the bioavailability of levodopa in the brain. Objectives This study evaluates the effect of Opicapone addition in PD‐LCIG patients, assessing its impact on motor ...
Fabiana Colucci +9 more
wiley +1 more source
CLINICAL AND FUNCTIONAL STUDIES ON THE VEGETATIVE DYSTONIA
, 1961 Rumiko Abei
openalex +2 more sources
Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”
Movement Disorders Clinical Practice, EarlyView.
João Moura +5 more
wiley +1 more source
12. Frequency Analysis and Power Spectrum of the Thalamic Activity in Parkinsonism and Dystonia
, 1968 Akira Nishimoto +2 more
openalex +2 more sources